TCS.Gen.modul 1. Université de Bordeaux (1er any)
| Subject | Credits | Type |
|---|---|---|
Fundamentals of Epidemiology |
3 ECTS |
Obligatory |
Fundamentals of Statistics |
3 ECTS |
Obligatory |
Assessment and Critical Analysis in Research |
6 ECTS |
Obligatory |
Analysis and Synthesis of Health Data |
6 ECTS |
Obligatory |
TCS.Gen.modul 2. Universitat Autònoma de Barcelona (1st year)
| Subject | Credits | Type |
|---|---|---|
Fundamentals of Clinical Pharmacology |
3 ECTS |
Obligatory |
Introduction to Pharmacoepidemiology |
3 ECTS |
Obligatory |
TCS.Gen.modul 3. University of Hertfordshire Higher Education Corporation (1st year)
| Subject | Credits | Type |
|---|---|---|
Principles of Pharmacovigilance |
3 ECTS |
Obligatory |
TCS.Gen.modul 4. Universitá degli Studi della Campania Luigi Vanvitelli (1st year)
| Subject | Credits | Type |
|---|---|---|
Principles of Drug Risk Communication |
3 ECTS |
Obligatory |
TCS.Gen.modul 5. Universitat Autònoma de Barcelona (2nd year)
| Subject | Credits | Type |
|---|---|---|
Critical Evaluation of Clinical Trials: Medicine based on Testing and Uncertainty |
3 ECTS |
Optional |
Drug Utilization Studies: Introduction and Quantitative Methods |
3 ECTS |
Obligatory |
Impact on Public Health of Adverse Medicine Reactions |
3 ECTS |
Optional |
Methods in clinical research, pharmacoepidemiology and drug efficacy evaluation |
3 ECTS |
Optional |
Clinical and Pharmacological Principles |
3 ECTS |
Obligatory |
TCS.Gen.modul 6. Universiteit Utrecht (2nd year)
| Subject | Credits | Type |
|---|---|---|
Advanced Methods for the Quantitative Assessment of Risks and Benefits in Decision-Making on Medicines |
3 ECTS |
Optional |
Introduction to Assessment of Medicines' Risk-Benefit Ratio |
3 ECTS |
Obligatory |
Basic Methods for the Quantitative Assessment of Medicines' Risks and Benefits |
3 ECTS |
Optional |
Principles of Pharmacoeconomics and Health Assessment Situations |
3 ECTS |
Optional |
TCS.Gen.modul 7. Research Project (1st year)
| Subject | Credits | Type |
|---|---|---|
Research Project (1st year) |
30 ECTS |
Obligatory |
TCS.Gen.modul 8. Universitá degli Studi della Campania Luigi Vanvitelli (2nd year)
| Subject | Credits | Type |
|---|---|---|
Information and Communication on the Risk-Benefit Ratio of Medicines |
3 ECTS |
Obligatory |
TCS.Gen.modul 9. University of Hertfordshire Higher Education Corporation (2nd year)
| Subject | Credits | Type |
|---|---|---|
The Regulatory Process in Pharmacovigilance |
3 ECTS |
Optional |
Regulatory Measures in Pharmacovigilance |
3 ECTS |
Obligatory |
TCS.Gen.modul 10. Erasmus Universitair Medisch Centrum Rotterdam (2nd year)
| Subject | Credits | Type |
|---|---|---|
Risk Substantiation and Quantification |
6 ECTS |
Optional |
Identifying Susceptibility to Adverse Medicine Reactions |
3 ECTS |
Optional |
Principles for Identifying Adverse Effects and Signs in Pharmacovigilance |
3 ECTS |
Obligatory |
TCS.Gen.modul 11. Université de Bordeaux (2nd year)
| Subject | Credits | Type |
|---|---|---|
Key Actors and Roles in Medicine Risk Communication: Duties and Challenges |
3 ECTS |
Optional |
Case Studies on Medicine Risk Communication |
3 ECTS |
Optional |
TCS.Gen.modul 12. Master's Thesis (2nd year)
| Subject | Credits | Type |
|---|---|---|
Master's Thesis |
30 ECTS |
Obligatory |
Specific skills
- KT01: Recognize new technologies for the identification and obtaining of bibliographic information or clinical data of patients or drug consumption, to solve problems in academic, regulatory or professional activity.
- KT02: Identify complex information related to the consequences of drug use.
- KT03: Effective team review in virtual, multicultural and interdisciplinary, professional and/or academic environments, with a public and/or private view of drug management.
- KT04: Demonstrate knowledge that provides a basis or opportunity to be original in the development and/or application of ideas, often in a research context.
-ST01: Apply methodological principles in the identification and quantification of drug risks, in the analysis of the benefit-risk relationship, in the assessment of the impact of drug use on public health and in risk communication.
-ST02: Critically argue, issue judgments by providing ideas based on the analysis of bibliographic information from scientific production in these areas and original data
-ST03: Interpret the information on drug toxicity and risk derived from its use according to the origin of the information, know its relevance communicating this finding to other professionals and the population
-CT01: Integrate the relationship between pharmacological characteristics, effectiveness and toxicity of a drug with the purpose of issuing a judgment on the risk to health by being able to propose regulatory measures can be taken in accordance with current international legislation.
-CT02: Evaluate problems in academic, regulatory and/or professional environments linked to pharmacovigilance and pharmacoepidemiology.
-CT03: Design studies to identify, measure or avoid the clinical and social consequences of adverse drug reactions.
Usa el traductor neuronal de Softcatalà
Title obtained
Màster Pharmacovigilance and Pharmacoepidemiology